Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Family Medicine | Genetic Disease

Clinical Trials: Epilepsy


A listing of clinical trials currently looking for volunteers to enroll in Epilepsy studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Alabaster : 113

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Huntsville : 110

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Northport : Neurology Clinic, P.C.

Eslicarbazepine Acetate Monotherapy Long Term Study

Arizona

Phoenix :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Phoenix : 001

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Phoenix : 013

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Phoenix : 013

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Phoenix : 001

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Phoenix : 107

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Phoenix : St. Joseph Hospital & Medical Center/Barrow Neurology Clinic

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Phoenix : 21st Century Neurology, a division of Xenoscience, Inc.

Eslicarbazepine Acetate Monotherapy Long Term Study

Phoenix : Clinical Research Consortium-Arizona

Eslicarbazepine Acetate Monotherapy Long Term Study

Phoenix : 004

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Phoenix : 120

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Phoenix :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Phoenix : United States, Arizona

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Phoenix : United States, Arizona

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Sun City : Arizona Neurological Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Tucson : Center for Neurosciences

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Tucson : 006

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tucson : 006

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Tucson : Center for Neurosciences

Eslicarbazepine Acetate Monotherapy Long Term Study

Tucson : University of Arizona, Health Sciences Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Tucson : United States, Arizona

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Arkansas

Little Rock : Clinical Trials, Inc.

Epilepsy and non-controlled partial seizures

Little Rock : Clinical Trials, Inc.

Epilepsy and treatment resistant partial onset seizures

Little Rock : Clinical Trials, Inc.

Epilepsy and Visual Field Change Study

View More »

Conway : Arkansas Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Jonesboro : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Little Rock :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Little Rock : Arkansas Children's Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Little Rock : 775

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Little Rock : 775

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Little Rock : 103

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Little Rock : Clinical Trials, Inc.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Little Rock : K&S Professional Research Services, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Little Rock : Clinical Trials Incorporated

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Little Rock : United States, Arkansas

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Little Rock : United States, Arkansas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Little Rock : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

California

Long Beach : CNS Network

A Phase III Study Investigating Intravenous Carbamazepine as a Replacement for Oral Carbamazepine in Epilepsy

View More »

Aneheim : Kaiser Permanente

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Berkley : Sutter East Bay Medical Foundation

Eslicarbazepine Acetate Monotherapy Long Term Study

Fresno : Neuro-Pain Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Fresno : 001

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Garden Grove : Collaborative Neuroscience Network

Eslicarbazepine Acetate Monotherapy Long Term Study

Irvine : 103

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Loma Linda : Faculty of Physicians and Surgeons of Loma Linda University

Eslicarbazepine Acetate Monotherapy Long Term Study

Loma Linda : United States, California

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Los Angeles : Childrens Hospital Los Angeles

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Los Angeles : VA Greater Los Angeles Healthcare System

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Los Angeles : GSK Investigational Site

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Los Angeles : GSK Investigational Site

Study in Pediatric Subjects With Epilepsy

Murriela : Viking Clinical Research

Eslicarbazepine Acetate Monotherapy Long Term Study

Murrieta : Viking Clinical Research Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Orange : 008

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Oxnard : 030

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Pasadena : Yafa Minazad

Eslicarbazepine Acetate Monotherapy Long Term Study

Sacramento : 025

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Sacramento : 045

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Sacramento : 108

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

San Francisco :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

San Francisco : 025

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

San Francisco : 025

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

San Francisco : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Santa Monica : Neurological Research Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Santa Monica : 057

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Torrance : Collaborative Neuroscience Network

Eslicarbazepine Acetate Monotherapy Long Term Study

Torrance : Collaborative Neuroscience Network, Inc.

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Ventura :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Ventura : United States, California

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Ventura : United States, California

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Ventura : 159

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Venture : Neurosearch II Inc

Eslicarbazepine Acetate Monotherapy Long Term Study

Colorado

Aurora :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Aurora : Neurosciences Clinic - University of Colorado Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

Aurora : United States, Colorado

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Denver : Denver Health

Eslicarbazepine Acetate Monotherapy Long Term Study

Denver : Denver Health and Hospital Authority

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Connecticut

Danbury : Associated Nuerologists, PC

Eslicarbazepine Acetate Monotherapy Long Term Study

Fairfield : 047

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

New Haven :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Delaware

Dover : 128

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

District of Columbia

Washington : 002

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Florida

Atlantis : JEM Research, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Bradenton :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Bradenton : Bradenton Research Center, Inc.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Bradenton : Bradenton Clinical Research

Eslicarbazepine Acetate Monotherapy Long Term Study

Bradenton : 025

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

View More »

Brenton :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Clearwater : 156

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Coral Gables : Miami Research Inc.

Eslicarbazepine Acetate Monotherapy Long Term Study

Gainesville :

3-Dimensional Accelerometer Sub-Study

Gainesville : University of Florida

Heart Rate Changes in Subjects With Epilepsy

Gainsville :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Gulf Breeze :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Gulf Breeze : Eisai Medical Services

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Gulf Breeze : NW FL Clinical Research Group, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Gulf Breeze :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Gulf Breeze : 108

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Gulf Breeze : United States, Florida

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Gulf Breeze : United States, Florida

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Hialeah : Palm Springs Research Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Hollywood : Infinity Clinical Research, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Hollywood : 140

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Jacksonville :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Jacksonville :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Maitland : Neurology Associates

Eslicarbazepine Acetate Monotherapy Long Term Study

Miami :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Miami : Miami VA Medical Center

Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Different Forms of Depakote

Miami : Miami Children's Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

Miami : Neuroscience Consultants

Eslicarbazepine Acetate Monotherapy Long Term Study

Miami : San Marcus Research Clinic

Eslicarbazepine Acetate Monotherapy Long Term Study

Miami : 110

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Ocala : 015

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Ocala : 161

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Orlando :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Orlando : Eisai Medical Services

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Orlando : 027

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Orlando : 027

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Orlando : Pediatric Neurology, PA

Eslicarbazepine Acetate Monotherapy Long Term Study

Ormond Beach : Neurology Associates of Ormond Beach

Eslicarbazepine Acetate Monotherapy Long Term Study

Panama City : Bay Neurological Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Panama City : 049

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Pensacola :

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Port Charlotte : Medsol Clinical Research Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Port Charlotte : 114

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Port Charlotte :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Sarasota : 044

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Sarasota : 012

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Tallahassee : Tallahasse Neurological Clinic

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Tallajassee : 164

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Tampa : 012

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Tampa :

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Tampa : 101

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Tampa : Pediatric Epilepsy & Neurology Specialists, PA

Eslicarbazepine Acetate Monotherapy Long Term Study

Tampa : 014

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Tampa : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Tampa : University of South Florida

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Tampa : United States, Florida

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Wellington : 019

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Wellington : Palm Beach Clinical Research Network, LLC

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Wellington : Palm Beach Clinical Research Network, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Wellington : 003

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Wellington : GSK Investigational Site

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Wellington : 103

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Wellington : GSK Investigational Site

Study in Pediatric Subjects With Epilepsy

Wellington : United States, Florida

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Wellington : United States, Florida

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Georgia

Atlanta : Neurotrials Research, Inc.

Do you have Seizures?

Atlanta : Neurotrials Research, Inc.

Do you suffer from Seizures?

Atlanta : Neurotrials Research, Inc.

Do You Suffer from Seizures?

View More »

Atlanta : 023

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Atlanta : 023

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Atlanta : Emory University

Does Memantine Improve Verbal Memory Task Performance in Subjects With Left Temporal Lobe Epilepsy and Memory Dysfunction?

Atlanta : PANDA Neurology and Atlanta Heachache Specialists

Eslicarbazepine Acetate Monotherapy Long Term Study

Atlanta : 112

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Atlanta : Emory Healthcare

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Augusta :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Augusta : 124

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Macon : 115

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Rome : 048

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Rome : Harbin Clinic

Eslicarbazepine Acetate Monotherapy Long Term Study

Rome : 118

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Idaho

Boise :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Boise : 039

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Boise : 039

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Boise : Consultants in Epilepsy and Nuerology

Eslicarbazepine Acetate Monotherapy Long Term Study

Boise : United States, Idaho

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

View More »

Boise : United States, Idaho

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Illinois

Chicago :

3-Dimensional Accelerometer Sub-Study

Chicago :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Chicago : 029

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Chicago : 029

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Chicago : University of Chicago

Heart Rate Changes in Subjects With Epilepsy

View More »

Chicago : UCMC

Study the Efficacy and Safety of Diazepam Auto-injector for Controled Episodes of Acute Repetitive Seizures

Chicago : University of Illinois at Chicago

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Flossmoor : 128

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Peoria : 005

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Peoria : 005

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Peoria : OSF Saint Francis Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Peoria : University of Illinois College of Medicine at Peoria

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Springfield : Southern Illinois University School of Medicine

Eslicarbazepine Acetate Monotherapy Long Term Study

Winfield : 017

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Winfield : 017

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Winfield : Central DuPage Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

Winfield : Central DuPage Hospital

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Indiana

Indianapolis : J.W.M. Neurology P.C.

Eslicarbazepine Acetate Monotherapy Long Term Study

Iowa

Ames : 020

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ames : 020

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ames : McFarland Clinic, PC

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Ames : McFarland Clinic, PC

Eslicarbazepine Acetate Monotherapy Long Term Study

Kansas

Manhattan : 053

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Manhattan : 122

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Manhattan : United States, Kansas

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Manhattan : United States, Kansas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Wichita :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

View More »

Wichita : Via Christi Epilepsy Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Kentucky

Bowling Green : 102

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Lexington :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Lexington : 780

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Lexington : 780

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Lexington : 108

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

View More »

Lexington : Bluegrass Epilepsy Research, LLC

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Lexington : Bluegrass Epilepsy Research, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Lexington : 108

Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy

Lexington : 130

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Lexington : Bluegrass Epilepsy Research

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Lexington :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Louisville : 123

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Louisville : University of Louisville Hospital

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Paducah : 117

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Louisiana

Hammond : ECommunity Research LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Hammond : 006

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Houma : Leonard J. Chabert Medical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Houma : 107

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

New Orleans :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

View More »

St Ruston : 145

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Maine

Scarborough : MMP Neuroloy

Eslicarbazepine Acetate Monotherapy Long Term Study

Maryland

Baltimore : John's Hopkins University School of Medicine

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Baltimore : Johns Hopkins University

Eslicarbazepine Acetate Monotherapy Long Term Study

Baltimore : United States, Maryland

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Bethesda : 008

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bethesda : 008

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Bethesda : 105

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Bethesda : Mid-Atlantic Epilepsy and Sleep Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Bethesda : Mid-Atlantic Epilepsy and Sleep Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Bethesda : 021

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Bethesda : Mid-Atlantic Epilepsy and Sleep Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Bethesda : United States, Maryland

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Waldorf : 112

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Waldorf :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Waldorf : 162

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Massachusetts

Boston : 030

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Boston : 030

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Boston : Massachusetts General Hospital

Cognitive Effects of Treatment of Interictal Discharges

Boston : Massachusetts General Hospital

Does Memantine Improve Verbal Memory Task Performance in Subjects With Left Temporal Lobe Epilepsy and Memory Dysfunction?

Boston : Brigham and Women's Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

View More »

Boston : 011

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Boston : 106

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Boston : Beth Israel Deaconess Medical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Boston : 153

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Burlington : Lahey Clinic

Eslicarbazepine Acetate Monotherapy Long Term Study

Michigan

Farmington Hills : QUEST Research Institute

Epilepsy Research Study for Seizures

View More »

Detroit : Children's Hospital of Michigan, Neurology

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Detroit : Wayne State University/Detroit Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Detroit : United States, Michigan

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Detroit : United States, Michigan

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Minnesota

Golden Valley : 009

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Golden Valley : 009

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Golden Valley : Minneappolis Clinic of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Golden Valley : 129

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Minneapolis : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

View More »

St Paul : 006

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

St. Paul : 104

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

St. Paul : Minnesota Epilepsy Group, P.A.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

St. Paul : 101

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

St. Paul : University of Minnesota & Prism Research

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

St. Paul : United States, Minnesota

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

St. Paul : United States, Minnesota

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Mississippi

Flowood : Biomedical Research Alliance of New York

Partial Epilepsy

View More »

Flowood : Precise Research Centers

Eslicarbazepine Acetate Monotherapy Long Term Study

Missouri

Chesterfield :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Chesterfield : 040

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Chesterfield : The Comprehensive Epilepsy Care Center for Children & Adults

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Chesterfield : Comprehensive Epilepsy Care Center for Children and Adults

Eslicarbazepine Acetate Monotherapy Long Term Study

Chesterfield :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

View More »

Chesterfield : 113

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Chesterfield : The Comprehensive Epilepsy Care Center for Children and Adults

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Chesterfield : United States, Missouri

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Kansas City : 008

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Kansas City : 151

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Springfield : 023

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

St Louis :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

St. Louis : PsychCare Consultants Research

Eslicarbazepine Acetate Monotherapy Long Term Study

St. Louis : United States, Missouri

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Montana

Missoula : 088

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

New Hampshire

Lebanon : 032

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Lebanon : 032

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

New Jersey

Camden : 020

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Gibbsboro : 037

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Gibbsboro : United States, New Jersey

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Hackensack :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Hackensack : Northeast Regional Epilepsy Group

Cognitive and Behavioral Effects of Lacosamide

View More »

Hackensack : Northeast Regional Epilepsy Group

Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin

Hackensack : Marcelo Lancman, MD

Eslicarbazepine Acetate Monotherapy Long Term Study

Hackensack : Northeast Regional Epilepsy Group

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Hamilton : 042

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Neptune :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Neptune : Jersey Shore University Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

New Brunswick : 015

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

New Brunswick : University Medicine and Dentistry of New Jersey

Eslicarbazepine Acetate Monotherapy Long Term Study

Newark : UMDNJ

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : Umdnj-Ubhc

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : University Hospital Pharmacy

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : University of Medicine and Dentistry of New Jersey

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Newark : UMDNJ DOC 8th Floor 8100

Eslicarbazepine Acetate Monotherapy Long Term Study

Somerset :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Voorhees : Clinical Research Center of New Jersey

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Voorhees : Eisai Medical Services

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Voorhees : 119

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

New York

Bronx : Biomedical Research Alliance of New York

Epilepsy - Adults

Bronx : Biomedical Research Alliance of New York

Epliepsy - Adults

Great Neck : Biomedical Research Alliance of New York

Are you taking Lamotrigine (Lamictal) or Valproic Acid (Depakote/Depakene)?

Great Neck : Biomedical Research Alliance of New York

Women with Epilepsy: Pregnancy Outcomes and Deliveries

New York : Biomedical Research Alliance of New York

Women with Epilepsy: Pregnancy Outcomes and Deliveries

View More »

Albany :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Albany : United States, New York

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Bronx : Montefiore Medical Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Bronx : Montefiore Medicical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Bronx : United States, New York

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Bronx : United States, New York

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Brooklyn : SUNY Downstate Medical Center

Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy

Brooklyn : 109

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Buffalo :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Buffalo : 105

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Cedarhurst : Five Towns Neuroscience Research

Eslicarbazepine Acetate Monotherapy Long Term Study

Lake Success :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

New York :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

New York : 022

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

New York : 109

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

New York : Weill Medical College of Cornell University

Lexapro for Major Depression in Patients With Epilepsy

New York : Columbia University Medical Center: Dept of Neurology

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

New York : United States, New York

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

New York : Columbia University

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Rochester :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Rochester : University of Rochester

Eslicarbazepine Acetate Monotherapy Long Term Study

Rochester : 104

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Rochester : University of Rochester

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Syracuse : 016

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Syracuse : 016

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Syracuse : SUNY Upstate Medical University

Eslicarbazepine Acetate Monotherapy Long Term Study

Syracuse : SUNY Upstate Medical University

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

North Carolina

Asheville : 010

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Asheville : 010

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Charlotte :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Charlotte : 158

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Durham : 003

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

View More »

Durham : 003

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Durham : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Durham : United States, North Carolina

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Greensboro : 131

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Hickory : PMG Research of Hickory, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

North Charleston :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Wilmington : Kendle International, Inc.

UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)

Winston-Salem : 014

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Winston-Salem : Department of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Winston-Salem : Wake Forest University Health Sciences

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

North Dakota

Bismarck : 139

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ohio

Akron : Akron Children's Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Akron : 106

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Akron : 106

Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy

Akron : 002

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Akron : 134

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

View More »

Canton : Ohio Clinical Research Partners, LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Canton : 027

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Canton : 150

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Cincinnati : 107

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Cleveland : Cleveland Clinic Updated

Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy

Cleveland : Cleveland Clinic

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Columbus : 778

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Columbus : 022

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Columbus : 111

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Columbus : United States, Ohio

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Dayton : 005

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Toledo :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Toledo : 002

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Toledo : 002

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Toledo : The University of Toledo

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Toledo : The University of Toledo Health Science Campus

Eslicarbazepine Acetate Monotherapy Long Term Study

Oklahoma

Oklahoma City : 043

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Oklahoma City : 043

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Oklahoma City : Lynn Health Science Institute

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Oklahoma City : Lynn Health Science Institute

Eslicarbazepine Acetate Monotherapy Long Term Study

Oklahoma City : Sooner Clinical Research

Eslicarbazepine Acetate Monotherapy Long Term Study

View More »

Oklahoma City : 013

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Oklahoma City : Lynn Health Science Institute

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Oklahoma City : United States, Oklahoma

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Oklahoma City : United States, Oklahoma

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Tulsa :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Tulsa : 054

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tulsa : Tulsa Clinical Research LLC

Eslicarbazepine Acetate Monotherapy Long Term Study

Tulsa : 018

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Oregon

Portland :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Pennsylvania

Abington : Biomedical Research Alliance of New York

Partial Epilepsy

View More »

Indiana : 121

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Philadelphia : 001

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Philadelphia : 015

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Philadelphia : 015

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Philadelphia : Thomas Jefferson University

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death

Philadelphia : University of Pennsylvania Health System

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Philadelphia : Thomas Jefferson University Comprehensive Epilepsy Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Philadelphia : Children's Hospital of Philadelphia

Eslicarbazepine Acetate Monotherapy Long Term Study

Philadelphia : Thomas Jefferson University

Eslicarbazepine Acetate Monotherapy Long Term Study

Philadelphia : 016

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Philadelphia : Drexel University College of Medicine, Dept of Neurology

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

Philadelphia : Temple University Health systems

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Philadelphia : United States, Pennsylvania

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Philadelphia : United States, Pennsylvania

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Philadelphia : Hospital University of PA

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Philadelpia : Temple University School of Medicine, Dept of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Phildelphia :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Pittsburgh : 016

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Pittsburgh : Children's Hospital of Pittsburgh of UPMC

Eslicarbazepine Acetate Monotherapy Long Term Study

Pittsburgh : 114

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Rhode Island

Cranston : Gus Stratton / Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Providence : 029

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

South Carolina

Beaufort : 021

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Beaufort : 021

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Charleston :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Charleston : 028

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Charleston : 028

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Charleston : Medical University of South Carolina

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Orangeburg : 149

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Spartanburg : 152

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Tennessee

Nashville : 004

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Nashville : 776

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Nashville : VU Department of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Nashville : 132

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Nashville : 109

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

View More »

Nashville : United States, Tennessee

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Nashville : Vanderbilt University Medical Center

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Texas

Dallas : Texas Neurology, PA

Double blind, randomized, historical control study of the safety and efficacy of Eslicarbazepine Acetate Monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs

View More »

Arlington : 050

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Arlington : Neurology Associates of Arlington, P.A.

Eslicarbazepine Acetate Monotherapy Long Term Study

Austin : 026

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Austin : 148

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Bownwood : Edwin A Green, Jr., MD

Eslicarbazepine Acetate Monotherapy Long Term Study

Dallas :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Dallas : 011

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Dallas : 035

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Dallas : 035

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Dallas : 011

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Dallas : 777

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Dallas : 110

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Dallas : Neurological Clinic of Texas, P.A.

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Dallas : Neurological Clinic of Texas, P.A.

Eslicarbazepine Acetate Monotherapy Long Term Study

Dallas : Texas Neurology, PA

Eslicarbazepine Acetate Monotherapy Long Term Study

Dallas : 117

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Dallas :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Dallas : GSK Investigational Site

Study in Pediatric Subjects With Epilepsy

Dallas : Neurological Clinic of Texas, P.A.

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Dallas : United States, Texas

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

Dallas : United States, Texas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Dallas : 154

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Fort Worth : United States, Texas

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Houston :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Houston : 049

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Houston : MD

Eslicarbazepine Acetate Monotherapy Long Term Study

Houston : UT Health Science Center at Houston/ Dept of Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Houston : 125

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Houston : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Houston : 117

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Houston : United States, Texas

Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data

Houston : Texas Children's Hospital

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Lubbock : 028

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Mansfield : Neurology Associates of Arlington, P.A.

Eslicarbazepine Acetate Monotherapy Long Term Study

San Antonio : Road Runner Research

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

San Antonio : Innovative Clinical Trials

Eslicarbazepine Acetate Monotherapy Long Term Study

San Antonio : Road Runner Research

Eslicarbazepine Acetate Monotherapy Long Term Study

San Antonio : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Spring : 022

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Temple :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Temple : Scott and White Memorial Hospital

Eslicarbazepine Acetate Monotherapy Long Term Study

Temple :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Temple : Scott & White Memorial Hospital

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Tomball : 146

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Utah

Salt Lake City : 102

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Virginia

Charlottesville : 036

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Charlottesville : 036

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Charlottesville : University of Virginia

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Charlottesville : University of Virginia

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Norfolk : 020

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

View More »

Norfolk : United States, Virginia

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Richmond : VCU Medical Center

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Richmond : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Washington

Bellevue : Neurological Associates of Washington

Eslicarbazepine Acetate Monotherapy Long Term Study

Renton : Rainier Clinical Research Center Inc.

Eslicarbazepine Acetate Monotherapy Long Term Study

Seattle : 033

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seattle : Pacific Medical Centers

Eslicarbazepine Acetate Monotherapy Long Term Study

West Virginia

Morgantown : West Virginia University

Eslicarbazepine Acetate Monotherapy Long Term Study

Wisconsin

Madison :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Madison : American Family Children's Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Madison : University of Wisconsin School of Medicine, Department of Neurology

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Madison : 052

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Madison : 139

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

View More »

Madison : United States, Wisconsin

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Marshfield : United States, Wisconsin

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Milwaukee : Regional Epilepsy Center

Eslicarbazepine Acetate Monotherapy Long Term Study

Milwaukee : 024

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Milwaukee :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Milwaukee : St. Luke's Milwaukee

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Argentina

Buenos Aires :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Cordoba :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Guaymallen :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Salta :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Australia

Bedford Park :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Chatswood : 075

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Chatswood : Australia, New South Wales

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Chatswood : 104

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Clayton :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

View More »

Clayton : 105

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

East Gosford : 106

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

East Gosford : 106

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Fitzory :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Fitzroy :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Fitzroy : Australia, Victoria

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Fitzroy : 101

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Heidelberg :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Heidelberg : 108

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Heidelberg West :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Heidelberg West : Australia, Vctoria

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Herston : 103

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Herston : 103

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Parkville :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Parkville : Australia, Victoria

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Randwick :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Randwick : 109

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Westmead : 102

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Woodville :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Woodville : 100

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Austria

Graz :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Graz : 15

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Innsbruck :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Innsbruck : 202

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Innsbruck : 070

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

View More »

Innsbruck : 11

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Innsbruck : Universitätsklinik für Neurologie; Arbeitsgruppe Epileptologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Inssbruck : 202

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Linz : 201

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Salzburg :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Salzburg : 12

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Salzburg : Universitätsklinik für Neurologie; Christian-Doppler-Klinik

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Wien :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Wien : 200

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Wien : 203

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Wien : 203

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Wien : 13

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Wien : Medizinische Universitat Wien Klinik fur Neurologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Wien : Neurologische Abteilung Krankenhaus Rosenhügel

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Belgium

Anderlecht :

Seizure Detection and Automatic Magnet Mode Performance Study

Antwerpen : 230

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Antwerpen : 132

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Assebroek : 134

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Brugge : 127

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

View More »

Brugge : 127

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Brussels : 201

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Brussels : Hospital Erasme

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Brussels : 225

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Brussels :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Brussels : 202

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Brussels : 203

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Brussels :

Seizure Detection and Automatic Magnet Mode Performance Study

Duffel : 133

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Edegem : 200

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Gent : 203

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Gent :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Gent : 131

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Ghent : University Hospital Ghent

Controlled Randomized Stimulation Versus Resection (CoRaStiR)

Ghent :

Seizure Detection and Automatic Magnet Mode Performance Study

Hasselt : 128

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Hasselt : 128

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Hechteleksel : 226

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Hechtel-Eksel : 226

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Kortrijk : 130

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Leuven : 202

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Leuven : 227

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Leuven : 227

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Leuven :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Leuven : 126

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Leuven : 201

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Leuven : 126

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Leuven : UZ Gasthuisberg

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Liege : 228

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Yvoir : Service de Neurologie; Clinique Universitaire UCL de Mont Godinne

Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

Brazil

Belo Horizonte : 104

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Florianopolis : 100

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Riberao Preto : 103

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Sao Paulo : 101

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bulgaria

Blagoevgrad : Multiprofile Hospital for Active Treatment "Pulse," AD, Town of Blagoegrad

Eslicarbazepine Acetate Monotherapy Long Term Study

Blagoevrad : 703

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

bul Hristo Botev : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Pleven : Univesity Multiprofile Hospital for Active Treatment "Dr. George Stranski," EAD, town of Pleven

Eslicarbazepine Acetate Monotherapy Long Term Study

Pleven : 803

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Pleven : 706

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Plovdiv : UMBAL Sveti Georgi, Klinika po pediatria i genetichni zabolyavania

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Ruse : 36

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Russe : 810

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Sofia : Otdelenie po Nevrologia; Vtora Mnogoprofilna Bolnitsa za Aktivno Lechenie

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Sofia : MBALNP Sveti Naum, Klinika po nervni bolesti za detsa

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Sofia : Second Multiprofile Hospital for Active Treatment

Eslicarbazepine Acetate Monotherapy Long Term Study

Sofia : UMHAT "Aleksandrovska"

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : UMHAT "Tsaritsa Yoanna -ISUL"

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : 4 MHAT Sofia

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : Diagnostic & Consultative Center "Sveta Anna" EOOD

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : First MHAT-Sofia

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sofia : 804

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Sofia : 806

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Sofia : 707

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 708

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 704

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 705

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 700

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : 702

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sofia : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Stara Zagora : MHAT "Prof. Stoyan Kirkovich"

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Varna : Diagnostic and Consultative Center "Equita" EOOD, town of Varna Neurology office

Eslicarbazepine Acetate Monotherapy Long Term Study

Varna : 701

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Veliko Tarnovo : 809

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Canada

Calgary : 075

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Calgary : 075

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Calgary : 155

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Greenfield Park : 077

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Greenfield Park : 077

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Greenfield Park : Neuro-Epilepsy Clinic/ Neuro Rive-Sud

Eslicarbazepine Acetate Monotherapy Long Term Study

Greenfield Park : 152

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Greenfield Park : 033

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Greenfield Park :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Greenfield Park : 152

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Hamilton : 035

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Hamilton : 156

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

London : 078

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

London : 078

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

London : London Health Sciences Centre, University Campus

Eslicarbazepine Acetate Monotherapy Long Term Study

London : 034

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Montreal : 079

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Montreal : Canada, Quebec

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Regina : 031

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Saskatoon : 080

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Saskatoon : 080

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke

Eslicarbazepine Acetate Monotherapy Long Term Study

St John's : 153

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Toronto : 076

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Toronto : 076

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Toronto : Canada, Ontario

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Toronto : 154

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Veilleux : 159

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Chile

Santiago :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Valdivia :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

China

Beijing : 1

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Beijing : 9

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Changchun : 12

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Changchun : 086015

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Chengdu : 6

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

View More »

Chongqing : 10

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Guangzhou : 16

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Guangzhou : 4

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Guangzhou : 5

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Guangzhou : 86008

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Kunming : 13

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nanchang : 86011

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Qingdao : 14

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shanghai : 2

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shanghai : 3

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Suzhou : 86022

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Taiyuan : 15

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Wuhan : 8

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Xi'an : 7

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Costa Rica

San Jose : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Croatia

Osijek : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Požega : General County Hospital Požega, Neurology department

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Rijeka : Polyclinic for neurology and psychiatry 'Interneuron

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Split : Clinical Hospital Centre Split

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Zagreb : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Czech Republic

Brno : 917

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Brno : 185

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Brno : 505

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Brno : Neurologická klinika, FN u Sv. Anny

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Brno : 185

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Brno - Cerna pole : Fakultni nemocnice Brno - Detska nemocnice

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Hradec Kralove : 915

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Hradec Kralove : 502

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Hradec Kralove : 736

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

HradecKralove :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Koterova : Poradna pro epilepsie

Eslicarbazepine Acetate Monotherapy Long Term Study

Kromeriz : 916

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kromeriz : 916

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Litomerice : 735

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ostrava : 251

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ostrava : 256

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ostrava : 251

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ostrava : 733

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ostrava - Třebovice : NZZ BORMED s.r.o.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Ostrava Poruba : 913

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ostrava Poruba : 913

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ostrava Porubo : 504

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Ostrava-Hrabuvka : 732

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ostrava-Trebovice :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Plzeň : Neurologická ambulance

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha : Evzen Nespor

Eslicarbazepine Acetate Monotherapy Long Term Study

Praha 1 : 252

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Praha 1 : 252

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Praha 10 :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Praha 10 : Clintrial, s.r.o.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha 11 : 767

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Praha 2 :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Praha 4 : 253

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Praha 4 : 253

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Praha 4 : 501

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Praha 4 : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Praha 4 - Krč : Fakultní Thomayerova nemocnice s poliklinikou, Neurologická klinika

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha 5 : Fakultni nemocnice v Motole

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Praha 5 : 184

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Praha 6 : Neurologicka ordinance

Eslicarbazepine Acetate Monotherapy Long Term Study

Praha 6 : Medical Services Prague s.r.o.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Praha 8 : Oddělení neurologie, FN Bulovka

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Rychnov nad Kneznou : CTC Rychnov nad Kneznou

Eslicarbazepine Acetate Monotherapy Long Term Study

Trebovicka : Cerebrovaskularni poradna s.r.o

Eslicarbazepine Acetate Monotherapy Long Term Study

Trutnov : 734

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Zlin : 250

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Zlin : 250

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Zlin : 180

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Zlin : 180

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Denmark

Aarhus : 059

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Aarhus : 930

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Glostrup : 086

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Herlev : 932

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Kobenhavn : 087

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Estonia

Tallinn :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Tartu :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Finland

Helsinki : 205

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Helsinki : 205

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Helsinki : 400

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Kuopio : 275

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kuopio : 207

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

View More »

Kuopio : 207

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Oulu : 278

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Oulu : 402

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Tampere : 276

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tampere : 276

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Tampere : 401

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Turku : 277

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Turku : 277

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

France

Amiens : 203

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Bethune : 301

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bethune : 301

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bethune : 200

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Bordeaux :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

View More »

Bron :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Broncedex :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Dijon : 303

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Garches :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Lille :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Lille Cedex : 202

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Limoges Cedex : 237

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lyon :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Marseille : 304

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Marseille : 613

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Marseille cedex 05 :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Montpellier : 305

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Montpellier : 305

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Montpellier Cedex 05 : Hôpital Gui de Chauliac, Explorations neurologiques et d'épileptologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Nancy : Hôpital Central - Service de Neurologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Paris : 201

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Paris :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Paris Cedex 13 : Groupement Hospitalier Universitaire Est, Pitié-Salpétrière; Clinique des Maladies du Système Nerveux

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Paris Cedex 19 :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Rouen :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Saint Priest en Jarez : 300

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Strasbourg : 231

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Strasbourg : 612

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Strasbourg : 610

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Toulon : 611

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Toulouse :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Toulouse Cedex :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Toulouse Cedex 9 :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Germany

Altenburg : 263

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Altenburg : 263

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Aschaffenburg : 258

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Aschaffenburg : 258

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Bad Neustadt : 337

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

View More »

Bad Neustadt : 265

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Bad Neustadt : 265

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Berlin :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Berlin : 329

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Berlin : 325

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Berlin : 329

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Berlin : 304

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Berlin : 270

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Berlin : 257

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Berlin : 262

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Berlin : 270

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Berlin : 257

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Berlin : 262

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Berlin : Epilepsieklinik Tabor - Ladeburger Straße 15

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Bernau :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Bernau : 326

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bernau : 326

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bernau : 303

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Bernaubei Berlin :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Bielefeld :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Bielefeld : 332

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bielefeld : 332

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bielefeld : 301

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Bielefeld : 065

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Bielefeld : 2

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Bonn :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Bonn : UKB Universitätsklinikum Bonn

Controlled Randomized Stimulation Versus Resection (CoRaStiR)

Bonn : 064

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Bonn : 1

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Bonn :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Bonn : Universitätsklinikum Bonn -AöR-

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Bonn : Klinik für Epileptologie Universität Bonn

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Bonn :

Seizure Detection and Automatic Magnet Mode Performance Study

Bonn : Germany, Nordrhein-Westfalen

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Celle : 266

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Dresden : 4

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Dresden : 267

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Erlangen :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Erlangen : 062

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Erlangen : 5

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Erlangen : Zentrum Epilepsie Erlangen

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Erlangen :

Seizure Detection and Automatic Magnet Mode Performance Study

Essen : 074

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Freiburg : Universitätsklinikum Freiburg

Controlled Randomized Stimulation Versus Resection (CoRaStiR)

Freiburg :

Seizure Detection and Automatic Magnet Mode Performance Study

Freiburg : Albert-Ludwigs-Universität Freiburg

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Giessen :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Goettingen : 331

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Goettingen : 331

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Göttingen : 260

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Hamburg : 066

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Hamburg : 911

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Kehl-Kork :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Kehl-Kork : 904

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kehl-kork : 300

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Kehl-Kork : 060

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Kehl-Kork : Diakonie Kork, Epilepsiezentrum

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Kiel : 327

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Kiel : Universitatsklinikum Schleswig-Holstein Campus Kiel

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Leipzig : 269

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Leipzig : 269

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Ludwigshaven : 069

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Luebeck : Pediatrics Department, University of Luebeck

Transcranial Direct Current Stimulation (tDCS) As A Tool For Prospective Responder Identification Before Vagus Nerve Stimulation (VNS) Implantation

Mainz :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Mainz : IZKS; Universitätsmedizin der Johannes-Gutenberg-Universität Mainz

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Marburg :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Marburg : 900

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Marburg : 256

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Marburg : Germany, Hessen

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Marburg : 256

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Muenchen : 264

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Munchen :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

München : Studienzentrum Dr. Stephan Arnold

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Munich :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Munich :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Munich : Klinikum der Universität München -Großhadern

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Munich : Germany, Bayern

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Osnabruck : 334

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Osnabruck : 259

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Osnabruck : 910

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Osnabrück : 259

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Ravensburg : 330

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ravensburg : 330

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Stuttgart : Neurologische Gemeinschaftspraxis am Seelberg

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Tubingen :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Tübingen : 068

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Tübingen : University Hospital Tübingen

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Ulm :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Ulm : 328

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Ulm : 328

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Ulm : Universitäts- und Rehabilitationskliniken Ulm (RKU), Klinik für Neurologie

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Westerstede : 333

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Westerstede : 061

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Westerstede : 7

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Westerstede : 913

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Greece

Alexandroupoli : 529

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Athens :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Athens : 521

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Heraklion : 522

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ioannina : 495

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Patras :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Thessaloniki :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Thessaloniki :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Thessaloniki : 493

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Thessaloniki : 520

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Thessaloniki : 524

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Thessalonikis : 490

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Thessalonikis : 490

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Guatemala

Guatemala ciudad : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Hong Kong

Hong Kong : 701

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Hong Kong : 701

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Hong Kong : 700

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Shatin : 700

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Hungary

Budapest :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Budapest : Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Budapest : Heim Pal Gyermekkorhaz, Neurologiai Osztaly

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Budapest : Semmelweis Egyetem, I. Sz. Gyermekgyogyaszati Klinika

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Budapest : Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaz, Gyermekneurologia

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

View More »

Budapest :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Budapest : 284

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Budapest : 283

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Budapest : 283

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Budapest : 284

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Budapest : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Debrecen :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Debrecen : 286

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Debrecen : 286

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Gyor : 282

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Gyor : 282

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Hodmezovasarhely : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Kecskemet :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Miskolc :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Nyiregyhaza : 287

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Pecs :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Pecs :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Pecs : 288

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Szeged : 285

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Szeged : 285

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

India

Bangalore :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Bangalore : 726

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bangalore : 726

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bangalore : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Bangalore : Bangalore Clinisearch

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

View More »

Bangalore : M.S. Ramaiah Medical College and Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Bangalore : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Bangalore, : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Dehradun :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Hyderabad :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Hyderabad : 727

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Hyderabad : St. Theresa's General Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Hyderabad : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Hyderbad : 727

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Kolkata : Nightingale Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Lucknow :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Madurai : 729

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Madurai : 729

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Mangalore :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Mangalore : Mallikatta Neuro Centre

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Mangalore : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Mumbai : 725

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Mumbai : 728

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Mumbai : 725

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Mumbai : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Nashik : 731

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Nashik : 731

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

New Delhi :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Pune : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Secunderabad :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Secunderabad : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Visakhapatnam :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Visakhapatnam : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Visakhapatnam : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Israel

Ashkelon :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Holon :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Nahariya :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Petach Tikva :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Ramat Gan :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Italy

Arezzo : 401

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Bari : 378

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bologna :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Brescia :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Cagliari : 313

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Faenza : 552

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Firenze : 380

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Firenze : 380

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Firenze :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Gallarate : 546

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Mantova :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Milano : 379

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Milano : 379

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Milano :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Modena : 309

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Monserrato : 377

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Monserrato : 377

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Monserrato : 337

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Napoli : 541

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Padova : 308

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Pavia :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Perugia : 376

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Perugia : 376

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Pietra Ligure : 559

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Pisa : 375

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Pisa : 375

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Pozzilli : 383

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Prato : 557

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Roma : 311

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Roma : 311

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Roma : 540

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Roma : 549

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Taranto : 542

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Torino : 547

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Torrette di Ancona : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Trieste : 551

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Troina : 400

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Japan

Aichi : 154

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Aichi : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Akita : 191

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Akita : 191

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Aomori : 132

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

View More »

Aomori : 19

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Asaka : 33

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Bunkyo : 184

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Bunkyo : 309

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Bunkyo : 184

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Bunkyo : 184

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Chiba : 160

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Chikushino : 159

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Daito : 21

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Ehime : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Fujisawa : 152

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fujisawa : 152

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Fujisawa : 12

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Fukuoka : 113

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 141

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 155

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 112

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 166

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Fukuoka : 112

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Fukuoka : 166

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Fukuoka : 113

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Fukuoka : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Fukuoka : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Fukushima : 187

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Gifu : 107

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Gifu : 107

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Gifu : 107

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Hachioji : 163

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hakodate : 183

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hamamatsu : 124

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Higashimatsuyama : 118

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Higashimatsuyama : 118

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Higashiosaka : 175

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Himeji : 162

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Himeji : 081004

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Himeji : 11

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Hirosaki : 101

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hirosaki : 30

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Hiroshima : 110

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hiroshima : 177

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Hiroshima : 303

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Hiroshima : 110

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Hiroshima : 23

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Hiroshima : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Hokkaido : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Iizuka : 165

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Iwanuma : 151

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 142

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 156

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 143

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kagoshima : 081012

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Kagoshima : 81012

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Kagoshima : 156

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kagoshima : 143

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kagoshima : 8

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kagoshima : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Kahoku-gun : 123

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kameda : 176

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kanagawa : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Kanazawa : 180

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kashihara : 150

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kashiwakazi : 153

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kashiwazaki : 153

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Katori : 167

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kawasaki : 161

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kawasaki : 17

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kitakusyu : 114

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kitakyusyu : 3

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kobe : 108

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kobe : 108

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Kobe : 81017

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Kodaira : 120

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kodaira : 302

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Kodaira : 120

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kodaira : 26

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Koga : 115

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kokubunji : 105

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kokubunji : 081010

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Kokubunji : 105

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kokubunji : 9

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Koshi : 306

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Koshi : 306

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Kyoto : 144

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Kyoto : 16

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Kyoto : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Miyagi : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Miyakonojo : 172

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Miyakonojo : 25

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Miyazaki : 181

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Miyazaki : 179

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Miyazaki : 186

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Moriyama : 136

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Moriyama : 136

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Nagoya : 189

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nagoya : 145

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nagoya : 305

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Nagoya : 305

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Naha : 192

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nara : 182

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nara :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Nara : 4

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Nara : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Neyagawa : 125

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Neyagawa : 081007

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Niigata : 106

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Niigata : 301

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Niigata : 10

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Niigata : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Niigata : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Nishinomiya : 173

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Nishirakawa-Gun : 188

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Ohmura : 116

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Ohmura : 116

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Okayama : 109

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Okayama : 109

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Okayama : 109

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Okayama : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Okayama : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Onojo : 308

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Osaka : 157

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Osaka : 174

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Osaka : 171

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Osaka : 15

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Osaka : 27

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Osaka : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Osakasayama : 24

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Osaka-sayama : 129

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Otaru : 130

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Otaru : 130

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Otsu : 137

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Saitama : 119

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Saitama : 178

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Saitama : 119

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Saitama : 081011

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Saitama : 119

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Saitama : 13

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Saito : 170

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sakai : 147

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sakai : 194

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sakai : 147

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sakai : 1

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Sapporo : 131

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sapporo : 117

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sapporo : 304

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sapporo : 117

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Sapporo : 304

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Sapporo : 117

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sapporo : 304

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sendai : 102

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sendai : 103

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Sendai : 103

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Sendai : 81020

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Sendai : 81031

A Study to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial Onset Seizures

Sendai : 102

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sendai : 103

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Sendai : 6

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Shimajiri : 168

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 133

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 134

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 138

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shimotsuke : 138

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Shizuoka : 121

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Shizuoka : 307

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Shizuoka : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Shizuoka : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Suita : 149

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Suita : 169

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takamatsu : 128

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takatsuki : 140

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takatsuki : 139

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Takatsuki : 139

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Tokyo : 190

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Tokyo : 148

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Tokyo : 190

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Tottori : 164

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Toyama : 185

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Toyonaka : 146

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Toyonaka : 2

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Tsu : 135

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Tsu : 135

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Tsu : 28

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Ube : 111

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Ube : 111

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Ube : 7

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Yamagata : 104

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Yamagata : 18

An Open Label Study of Levetiracetam Monotherapy in Newly Diagnosed Epilepsy With Partial Onset Seizure

Yokohama : 193

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Yokohama : 193

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Yonago : 126

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Yonago : 127

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Yufu : 310

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Korea, Republic of

Anyang : 20

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Busan :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Busan : 753

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Busan : 753

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Busan : Dong-A University Medical Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

View More »

Busan : 17

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Busan : 16

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Busan : 10

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Busan : 05

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Busan : 8

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Busan : 21

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Busan : 14

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Busan : 9

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Daegu : Keimyung University Dongsan Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Daegu : 12

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Daegu : 13

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Daegu : 521

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Daegu : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Daejeon : Chungnam National University Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Daejeon : 06

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Daejeon : 18

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Daejeon : 10

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Dajeon : 518

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Goyang-si : 08

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Goyang-si : 09

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Gwangju : 752

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Gwangju : 07

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Gwangju : 15

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Gyeonggi-do : Hallym University Sacred Heart Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Incheon : 7

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Kyunggi-do : 19

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seongnam-si : 14

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seongnam-si : 11

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Seoul : Samsung Medical Center/ Department of Pediatrics, Pediatric Neurology

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Seoul : Yonsei University College of Medicine Severance Hospital / Department of Pediatric Neurology

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Seoul : Seoul National University Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Seoul : 754

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seoul : 750

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seoul : 751

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Seoul : 754

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Seoul : 750

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Seoul : 751

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Seoul : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Seoul : GSK Investigational Site

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Seoul : Asan Medical Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Seoul : Samsung Medical Center

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Seoul : Seoul National University Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Seoul : Korea University Anam Hospital

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Seoul : 11

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 01

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 02

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 12

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 13

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 15

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 03

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 04

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Seoul : 1

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 3

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 5

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 6

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 16

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 17

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 2

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 4

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 18

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Seoul : 519

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Seoul : 516

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Seoul : 517

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Seoul : 520

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Seoul : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Ulsan : 19

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subject With Partial Epilepsy

Ulsan : 22

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Latvia

Riga :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Riga :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Riga : 751

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Riga : 752

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Valmiera :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

View More »

Valmiera :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Ventspils : 750

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lithuania

Alytus : 727

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Kaunas : 724

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Kaunas : 725

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Vilnius : 728

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Vilnius : 726

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Malaysia

Ipoh : Paediatric Department

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Kuala Lumpur : Hospital Kuala Lumpur

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Kuala Lumpur : GSK Investigational Site

Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures

Mexico

Aguascalientes : 106

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Aguascalientes : 129

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Aguascalientes : 129

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Aguascalientes : 602

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Aguascalientes : 542

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Aguascalientes : 180

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Chihuahua : 546

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Chihuahua : 185

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Chihuahua : 183

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ciudad Juarez : 184

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ciuliacan : 609

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Culiacan : 101

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Culiacan : 127

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Culiacan : 127

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Guadalajara : 104

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Guadalajara : 126

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Guadalajara : 128

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Guadalajara : 126

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Guadalajara : 128

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Guadalajara : Pfizer Investigational Site

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

Guadalajara : 603

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Guadalajara : 189

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Mexico D.F. : 130

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Mexico D.F. : 130

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Mexico D.F. : 604

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Mexico DF : 193

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Mexico DF : 195

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Mexico DF : 181

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Monterrey : 105

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Monterrey : 610

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Monterrey : 186

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Monterrey : 188

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Monterrey : 187

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Polanco : 125

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Polanco : 125

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Polanco : 182

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Puebla : 190

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

San Luis Potosi : 103

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

San Luis Potosi : 607

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

San Luis Potosi : 547

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Netherlands

Deh Haeg :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Enschede : Medisch Spectrum Twente

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Heemstede : 401

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Heeze :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Heeze : 400

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

View More »

Heeze : 400

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Heeze : Expertisecentrum Voor Epileptologie-Kempenhaeghe

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Heeze : Epilepsiecentrum Kempenhaeghe

Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment

Heeze :

Seizure Detection and Automatic Magnet Mode Performance Study

Maastricht : Maastricht University Medical Center

Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment

Oosterhout : 402

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Rotterdam :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Ultrecht :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Zwolle : 403

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Norway

Oslo :

Seizure Detection and Automatic Magnet Mode Performance Study

Philippines

Cebu City : Cebu Doctors' University Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Manila : University of Santo Tomas Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Quezon City : Philippine Children's Medical Center

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Quezon City : St. Luke's Medical Center

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Sta. Cruz : Center for Neurodiagnostic and Therapeutic Services

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Poland

Bialystok : 475

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Bialystok : 475

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bialystok : 792

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Bialystok : 404

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Dansk :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

View More »

Gdansk :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Gdansk : Klinika Neurologii Rozwojowej

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Gdansk : 485

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Gdansk : 403

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Gdansk : 335

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Gdańsk : "Klinika Neurologii Rozwojowej

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Gliwice : NZOZ Vito-Med Sp. Zo.o

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Goczalkowice Zdroj : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Katawice :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Katowice : 478

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Katowice : 480

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Katowice : 795

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Katowice : 481

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Katowice : 478

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Katowice : 480

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Katowice : 795

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Katowice :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Katowice : SPSK Nr 7 SUM w Katowicach, Gornoslaskie CM im. Prof. Leszka Gieca

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Katowice : NZOZ Diagnomed

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Katowice : 340

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Katowice : 334

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Katowice : 340

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Katowice : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Kielce : 406

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Krakow :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Krakow : 476

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Krakow : 793

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Krakow : 793

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Krakow : 476

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Krakow : Malopolskie Centrum Medyczne

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Krakow : Centrum Leczenia Padaczki i Migreny

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Krakow :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Krakow : 402

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Kraków : Centrum Leczenia Padaczki i Migreny

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Kraków : Małopolskie Centrum Medyczne s.c.

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Lodz :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Lodz : Centrum Terapii Wspolczesnej

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

Lodz : Centrum Terapii Współczesnej

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Lublin :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Lublin : 342

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Olsztyn. :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Poznan :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Poznan : Katedra i Klinika Neurologii Wieku Rozwojowego

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Poznan : 477

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Poznan : 479

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Poznan : 482

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Poznan : 479

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Poznan : 477

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Poznan :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Poznan : 401

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Poznan : 341

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Rzeszow : 408

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Szczecin : 407

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Szczecin : 338

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Warsazawa :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Warszawa : 794

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Warszawa :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Warszawa : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Warszawa :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Warszawa : 343

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Wroclaw : Oddzial Neurologii Dzieciecej

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Wroclaw : 405

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Zabrze :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Portugal

Amadora Amadora : Hospital Prof. Doutor Fernando Fonseca, EPE

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Coimbra : 360

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Coimbra : AIBILI - Centro de Estudos de Biodisponibildade

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Coimbra : 360

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lisboa : 362

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

View More »

Lisboa : 365

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lisboa : 362

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lisbon : Hospital de Santa Maria

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Lisbon : Centro Hospitalar de Lisboa Norte, EPE - Hospital de Staª Maria - Centro de Estudos Egas Moniz

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Lisbon : Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Egas Moniz

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Porto : Centro Hospitalar de São João E.P.E.

Product Surveillance Registry- Deep Brain Stimulation for Epilepsy

Porto : 366

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Santa Maria Da Feira : 361

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Viana do Castelo : Unidade Local de Saúde de Alto Minho, EPE - Hospital de Santa Luzia - Serviço de Neurologi

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Vila Real : Centro Hospitalar de Trás-os -Montes e Alto-Douro, EPE - Hospital de São Pedro - Serviço de Neurologia

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Puerto Rico

Hato Rey : Hospital Del Maestro

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Rio Piedras : Centro Neurodiagnostico

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

San Juan : 038

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Romania

Brasov : C.M.D.T.A. Neomed

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Bucharest : 096

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Bucharest : 099

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Bucuresti : Spitalul Clinic de Psihiatrie "Prof. Dr. Al. Obregia"

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Bucuresti : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

View More »

Bucuresti : 576

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Bucuresti : Cabinet Medical Individual "Dr. Roceanu Adina Maria" -Neurologie, Neurofiziologie (EEG, EMG, PEC)

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Bucuresti : 576

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Campulung Muscel : Sc Clubul Sanatatii Srl

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Cluj-napoca : 569

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Cluj-Napoca : 569

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Cluj-napoca : 810

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Constanta : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Craiova : 578

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Craiova : 812

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Craiova; Jud. Dolj : Spitalul Clinic de Neuropsihiatrie Craiova

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Iasi : 570

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Iasi : 570

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lasi : 097

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Lasi : 098

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Oradea : 814

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sibiu : Spitalul de Psihiatrie Dr. Ghe. Preda

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Sibiu : 571

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Sibiu : 571

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Sibiu : 577

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Targu Mures : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Targu Mures : 095

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Targu Mures : 038

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Targu Mures : 572

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Targu Mures : 813

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Timisoara : 568

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Timisoara : 811

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Russian Federation

Belgorod : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Ekaterinburg : Sverdlovsk region neuropsychiatric clinic

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Kazan : 501

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kazan : 506

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Kazan : 501

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Kazan : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Kazan :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Kazan : 387

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Kazan : 389

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Kazan : 830

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Kazan : 831

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Kemerovo : Region psychiatric clinic

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Kirov : 396

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Krasnodar : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Moscow : 502

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : 503

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : 505

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : 507

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Moscow : 502

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Moscow : 503

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Moscow : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Moscow :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Moscow : Moscow regional psychiatric hospital

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Moscow : 394

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Moscow : 834

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Nizhny Novgorod : 509

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Nizhny Novgorod : 390

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Novosibirsk : State Medical University

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Novosibirsk : 392

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Novosibirsk : 833

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Saint-Petersburg : State psychiatric hospital №6

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Samara : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Samara :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Samara : State Medical University

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Saransk : Republican psychiatric dispensary

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Smolensk : 508

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Smolensk : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Smolensk : State Medical Academy

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Smolensk : 386

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Smolensk : 832

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

St Petersburg :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

St.-Petersburg : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Tyumen :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Yaroslavi :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Serbia

Belgrade :

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Belgrade : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Belgrade : Clinic of Neurology, Clinical Center of Serbia

Eslicarbazepine Acetate Monotherapy Long Term Study

Palmoticeva : Institute of Mental Health, Department of epilepsy and clinical neurophysiology

Eslicarbazepine Acetate Monotherapy Long Term Study

Singapore

Singapore : KK Women's and Children's Hospital

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Slovakia

Bratislava : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Dolni Kubin : 594

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Dolni Kubin : 594

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Dubnica Nad Vahom : 598

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Dubnica nad Vahom : 598

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Hlohovec : 596

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Hlohovec : 596

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Krompachy : 600

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Levoca : 595

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Tornala : 599

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Zilina : Pfizer Investigational Site

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Zilina : 601

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

South Africa

Cape Town :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Spain

Alicante : 415

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Almeria : 525

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Almeria : 592

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Badalona : 536

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Badalona :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

View More »

Badalona : 422

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Bajo Sevilla : 597

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Barcelona : 528

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Barcelona : 529

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Barcelona : 528

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Barcelona : 529

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Barcelona :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Barcelona : 413

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Barcelona : 309

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Barcelona : IMAS Hospital del Mar

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Barcelona : Hospital de la Santa Creu i Sant Pau

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Barcelona : Hospital Universitari Vall d'Hebron

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Barcelona : 413

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Barcelona : 590

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Girona : 417

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Girona : 417

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Granada :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

La Laguna : 419

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Madrid :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Madrid : 306

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Madrid : Hospital Clínico San Carlos

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Madrid : Hospital General Universitario Gregorio Marañón

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Madrid : Spain, Madrid

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Madrid : 416

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Malaga : 054

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Manresa : 051

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Mataro : 055

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Mirasierra : Spain, Madrid

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Murcia - El Palmar :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Murcia (El Palmar) : 421

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Oviedo : 053

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Palma de Mallorca : 503

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Palma de Mallorca : 301

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

San Sebastian : 418

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

San Sebastian de los Reyes : 595

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Santander :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Santander : 304

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Santiago de Compostela : 532

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Santiago de Compostela : 20

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Santiago de Compostela : 414

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Santiago de Compostela : 596

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Sevilla : 502

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Sevilla :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Sevilla : 050

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Sevilla : Hospital Universitario Virgen Macarena

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Sevilla : Spain, Andalucia

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Terrassa : Spain, Terassa

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Terrassa : 598

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Valencia : 527

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Valencia : 527

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Valencia :

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Valencia : 308

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Valencia : 594

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Valladolid : 526

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Valladolid : 526

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Valladolid : 599

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Vigo : 534

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Zaragoza : 303

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Sweden

Goteborg : 551

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Goteborg : 551

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Göteborg : 440

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Göteborg : 102

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Göteborg : 440

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Linkoping : 552

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Linköping : 442

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Linköping : 101

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Motala : 100

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Stockholm : 550

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Stockholm : 550

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Stockholm : 438

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Umea : 442

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Switzerland

Biel : 654

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lausanne : 892

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Lugano : 105

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Sankt Gallen : 106

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

St Gallen : 890

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

View More »

St. Gallen : 647

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Taiwan

Changua : 802

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Taichung : 801

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tainan : 800

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tainan : 804

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Tainan : 800

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

View More »

Taoyuan Hsien : 803

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Thailand

Bangkok : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Khon Kaen : 698

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Muang : Pfizer Investigational Site

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Turkey

Adana : 713

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ankara : 714

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Eskisehir : 710

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Istanbul : 719

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Istanbul : 715

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

View More »

Istanbul : 711

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Izmir : 717

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Trabzon : 718

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Ukraine

Chernihiv : 622

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Dnepropetrovsk :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Dnepropetrovsk : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Dnipropetrovsk : Communal Institution "Dnipropetrovsk Regional Clinical Hospital named after l.l. Mechnikov" Regional Center of psychosomatic disorders, Psychoneurology department for patients with psychosomatic disorders and borderline conditions

Eslicarbazepine Acetate Monotherapy Long Term Study

Dnipropetrovsk : 628

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

View More »

Donetsk : Communal Medical and Preventive Treatment Institution "Regional Clinical Psychiatric Hospital" Donetsk National Medical University

Eslicarbazepine Acetate Monotherapy Long Term Study

Kharkiv : State Institution "Institute of neurology, psychiatry, and narcology of AMS of Ukraine" Department of cerebrovascular patology

Eslicarbazepine Acetate Monotherapy Long Term Study

Kharkiv : Ukraine, Kharkiv

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Kharkov :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Kharkov : State Treatment and Prevention Institution " Central clinical hospital of Ukrzalizntysya" Neurology Department of Neuropathology and Child Neurology

Eslicarbazepine Acetate Monotherapy Long Term Study

Kharkov : State Institution "Institute of the Health Care of Children and Adolescents of Academy of Medical Sciences of Ukraine Dept of Psych

Eslicarbazepine Acetate Monotherapy Long Term Study

Kharkov : 626

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Kiev : State Institution Railway Clinical Hospital #1 of Kiev Railway Station of DTGO South Western Railroad Psycho-neurological Department

Eslicarbazepine Acetate Monotherapy Long Term Study

Kyiv : 629

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Kyiv : 630

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lugansk : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Luhansk : 621

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Lviv :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Lviv : Communal Institution "Lviv Regional Clinical Psych Hospital"

Eslicarbazepine Acetate Monotherapy Long Term Study

Odesa : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Odesa : 625

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Odessa :

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Odessa : Communal Institution "Odessa Regional Clinical Psych Hospital #1" Department of Day Care

Eslicarbazepine Acetate Monotherapy Long Term Study

Odessa : Ukraine, Odessa

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Oleksandrivka village, Odesa : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Poltava : Poltava Regional Clinical Psychiatric Hospital named O.F. Maltsev

Eslicarbazepine Acetate Monotherapy Long Term Study

Poltava : GSK Investigational Site

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).

Simferopol : Crimean Republican Institution "Clinical Psychiatric Hospital #1"

Eslicarbazepine Acetate Monotherapy Long Term Study

Simferopol : 632

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Ternopil : Ukraine, Ternopil

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Vinnytsa : 633

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Vinnytsia : Communal Institution "Vinnystsia Regional Psycho-Neurological Hospital named after O.I. Yuschenko, Vinnytsia National Medical University named after M.I. Pirogov, Dispensary department, Department of Psychiatry and Addictology

Eslicarbazepine Acetate Monotherapy Long Term Study

Vinnytsya : Ukraine, Vinnytsya

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

Zaporizhzhya : Ukraine, Zaporizhzhya

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

United Kingdom

Birmingham : 603

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Birmingham : 603

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Birmingham : 466

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Birmingham : Foundation Trust Queen Elizabeth Hospital Birmingham

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Cardiff : 606

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

View More »

Glasgow : 472

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

London : 604

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

London : 600

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

London : 600

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

London : 601

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

London :

Seizure Detection and Automatic Magnet Mode Performance Study

London : 468

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Middlesborough : 605

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Middlesborough : 605

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Morriston : 602

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Morriston : 602

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures

Newcastle : 607

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Sheffield :

Seizure Detection and Automatic Magnet Mode Performance Study

Staffordshire : 600

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Swansea : 465

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Truro : 601

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Truro : 601

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Partial Onset Seizures